Europe (WHO region) vs Israel: New cases tested for RR-/MDR-TB
Europe (WHO region)
88.0%
in 2024
Israel
100.0%
in 2024
Europe (WHO region) rank
3rd
Israel rank
1st
New cases tested for RR-/MDR-TB over time
- Europe (WHO region)
- Israel
How they compare
Israel currently reports 100.0% against 88.0% in Europe (WHO region), a difference of 12.0%.
That makes Israel's figure about 1.1 times Europe (WHO region)'s.
Across all 20 years both countries report, Israel has been ahead every year.
Europe (WHO region) ranks 3rd and Israel ranks 1st of 11 groups.
Israel has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Europe (WHO region) | Israel | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 47.2% | 100.0% | 52.8% | Israel |
| 2010s | 84.6% | 99.2% | 14.6% | Israel |
| 2020s | 90.8% | 100.0% | 9.2% | Israel |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new cases tested for rr-/mdr-tb, Europe (WHO region) or Israel?
- Israel, at 100.0% against 88.0% in Europe (WHO region) as of 2024.
- What is the difference in new cases tested for rr-/mdr-tb between Europe (WHO region) and Israel?
- 12.0%, with Israel ahead.
- How many years of comparable data are there for Europe (WHO region) and Israel?
- 20 years are reported by both, from 2005 to 2024.
- How do Europe (WHO region) and Israel rank globally for new cases tested for rr-/mdr-tb?
- Europe (WHO region) ranks 3rd and Israel ranks 1st of 11 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.